Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -0.45% | +6.40% | +1.02% | +0.80% | -1.82% | — | — | — | -12.70% |
| Total return | -0.45% | +6.74% | +1.26% | +0.80% | -1.55% | — | — | — | -12.44% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Jan 24, 2023. Past performance does not guarantee future results.
Fees
| Net expense ratio | — | Annual cost of a $10,000 investment | — |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Apr 17, 2023 · portfolio reporting date from the data provider; holdings are not live positions. 72 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | ISHARES GLOBAL HEALTHCARE | IXJ | 8.78% | 246 | $0.00 |
| 2 | THERMO FISHER | TMO | 5.40% | 22 | $0.00 |
| 3 | NOVO NORDISK-B | NOVOB | 5.22% | 125 | $0.00 |
| 4 | JOHNSON&JOHNSON | JNJ | 5.15% | 75 | $0.00 |
| 5 | PFIZER INC | PFE | 5.12% | 280 | $0.00 |
| 6 | INTUITIVE SURGIC | ISRG | 5.02% | 36 | $0.00 |
| 7 | DANAHER CORP | DHR | 5.02% | 39 | $0.00 |
| 8 | ABBOTT LABS | ABT | 4.93% | 99 | $0.00 |
| 9 | EDWARDS LIFE | EW | 4.82% | 105 | $0.00 |
| 10 | BIONTECH SE | BNTX | 4.08% | 38 | $0.00 |
| 11 | REGENERON PHARM | REGN | 3.83% | 16 | $0.00 |
| 12 | HOYA CORP | 7741 | 3.33% | 52 | $0.00 |
| 13 | VERTEX PHARM | VRTX | 3.06% | 40 | $0.00 |
| 14 | AGILENT TECH INC | A | 3.02% | 46 | $0.00 |
| 15 | SEAGEN INC | SGEN | 2.09% | 28 | $0.00 |
| 16 | WEST PHARMACEUT | WST | 1.94% | 11 | $0.00 |
| 17 | LABORATORY CP | LH | 1.78% | 15 | $0.00 |
| 18 | US DOLLARS | — | 1.72% | 3.98K | $0.00 |
| 19 | CHUGAI PHARMA CO | 4519 | 1.47% | 91 | $0.00 |
| 20 | WATERS CORP | WAT | 1.35% | 9 | $0.00 |
| 21 | BIO-RAD LABS-A | BIO | 1.26% | 4 | $0.00 |
| 22 | PERKINELMER INC | PKI | 1.25% | 17 | $0.00 |
| 23 | COOPER COS INC | COO | 1.23% | 7 | $0.00 |
| 24 | HOLOGIC INC | HOLX | 1.16% | 38 | $0.00 |
| 25 | QUEST DIAGNOSTIC | DGX | 1.10% | 18 | $0.00 |
| 26 | EUROFINS SCIEN | ERF | 1.00% | 19 | $0.00 |
| 27 | SARTORIUS STEDIM | DIM | 0.87% | 4 | $0.00 |
| 28 | FISHER & PAYKEL | FPH | 0.82% | 86 | $0.00 |
| 29 | QIAGEN NV | QGEN | 0.79% | 36 | $0.00 |
| 30 | CSPC PHARMACEUTICAL GROUP | 1093 | 0.65% | 1.25K | $0.00 |
| 31 | BRUKER CORP | BRKR | 0.53% | 16 | $0.00 |
| 32 | GLOBUS MEDICAL I | GMED | 0.50% | 15 | $0.00 |
| 33 | CRISPR THERAPEUT | CRSP | 0.49% | 11 | $0.00 |
| 34 | SINO BIOPHARM | 1177 | 0.49% | 1.44K | $0.00 |
| 35 | TECAN GROUP AG-R | TECN | 0.48% | 2 | $0.00 |
| 36 | ENCOMPASS HEALTH | EHC | 0.48% | 15 | $0.00 |
| 37 | ONO PHARMA | 4528 | 0.46% | 48 | $0.00 |
| 38 | HALOZYME THERAPE | HALO | 0.36% | 21 | $0.00 |
| 39 | BLUEPRINT MEDICI | BPMC | 0.34% | 8 | $0.00 |
| 40 | INNOVIVA INC | INVA | 0.30% | 41 | $0.00 |
| 41 | INMODE LTD | INMD | 0.30% | 10 | $0.00 |
| 42 | QUIDEL CORP | QDEL | 0.30% | 5 | $0.00 |
| 43 | Ipsen SA | IPN | 0.29% | 7 | $0.00 |
| 44 | CATALYST PHARMACEUTICALS | CPRX | 0.29% | 125 | $0.00 |
| 45 | INDIVIOR PLC | INDV | 0.29% | 234 | $0.00 |
| 46 | BIOMERIEUX | BIM | 0.29% | 6 | $0.00 |
| 47 | IRONWOOD PHARMAC | IRWD | 0.29% | 51 | $0.00 |
| 48 | PREMIER INC-CL A | PINC | 0.28% | 17 | $0.00 |
| 49 | TOWA PHARMA CO | 4553 | 0.27% | 21 | $0.00 |
| 50 | SAGE THERAPEUTICS INC | SAGE | 0.27% | 14 | $0.00 |
| 51 | AMVIS HOLDINGS I | 7071 | 0.27% | 9 | $0.00 |
| 52 | NAKANISHI INC | 7716 | 0.26% | 28 | $0.00 |
| 53 | CHINA GRAND PHAR | 512 | 0.26% | 778 | $0.00 |
| 54 | TONGRENTANGCM | 3613 | 0.26% | 467 | $0.00 |
| 55 | MERIDIAN BIOSCI | VIVO | 0.26% | 32 | $0.00 |
| 56 | ANTARES PHARMA INC | ATRS | 0.26% | 170 | $0.00 |
| 57 | PREMIER ANTI-AGI | 4934 | 0.25% | 5 | $0.00 |
| 58 | BML Inc | 4694 | 0.25% | 15 | $0.00 |
| 59 | LEMAITRE VASCULA | LMAT | 0.25% | 11 | $0.00 |
| 60 | CHINA MEDICAL SYSTEM | 867 | 0.25% | 327 | $0.00 |
| 61 | LABORATORIOS FARMACEUTICO | ROVI | 0.25% | 9 | $0.00 |
| 62 | NIPPON SHINYAKU | 4516 | 0.25% | 7 | $0.00 |
| 63 | TAKARA BIO INC | 4974 | 0.25% | 21 | $0.00 |
| 64 | ABCELLERA BIOLOG | ABCL | 0.25% | 35 | $0.00 |
| 65 | Nihon Kohden Corp | 6849 | 0.24% | 17 | $0.00 |
| 66 | EIKEN CHEMICAL | 4549 | 0.24% | 30 | $0.00 |
| 67 | H.U. GROUP HOLDINGS INC | 4544 | 0.24% | 21 | $0.00 |
| 68 | UNIQURE NV | QURE | 0.24% | 18 | $0.00 |
| 69 | PACIRA BIOSCIENC | PCRX | 0.23% | 11 | $0.00 |
| 70 | FULGENT GENETICS INC | FLGT | 0.23% | 7 | $0.00 |
| 71 | ORGANOGENESIS HO | ORGO | 0.23% | 41 | $0.00 |
| 72 | VITROLIFE AB | VITR | 0.22% | 10 | $0.00 |
Click a ticker to see every ETF that owns it.
Distributions
| Yield (TTM) | — | Paid (last 12 months) | — |
| Frequency | Irregular | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Dec 15, 2022 | Last payment | $0.0270 (Dec 21, 2022) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Dec 15, 2022 | Dec 16, 2022 | Dec 21, 2022 | $0.0270 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
Liquidity
| Volume today | 518 | Average volume | — |
| AUM | — | Premium/Discount | — |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing. No official links available from our data source for this fund yet.
Latest News for APXH
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.
APXH